Not applicableStudy completedNCT05954546What this trial is testingCompare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial SettingsWho this might be right forMetastatic Melanoma Pfizer 275
Not applicableStudy completedNCT01879657What this trial is testing68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)Who this might be right forNeuroendocrine Carcinoma Radio Isotope Therapy of America 169
Testing effectiveness (Phase 2)Looking for participantsNCT07057596What this trial is testingNeoadjuvant Tebentafusp in Patients With Metastatic Uveal MelanomaWho this might be right forMestastatic Uveal Melanoma Grupo Español Multidisciplinar de Melanoma 19
Early research (Phase 1)Study completedNCT00527761What this trial is testingTaxotere/Temodar/Cisplatin Study in Melanoma PatientsWho this might be right forMetastatic Melanoma M.D. Anderson Cancer Center 23
Early research (Phase 1)Study completedNCT01656642What this trial is testingA Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic MelanomaWho this might be right forMalignant Melanoma Genentech, Inc. 67
Early research (Phase 1)Active Not RecruitingNCT05176470What this trial is testingNeoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma PatientsWho this might be right forLocally Advanced MelanomaPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more Richard Wu 2
Testing effectiveness (Phase 2)Study completedNCT00466687What this trial is testingErlotinib and Bevacizumab in Treating Patients With Stage IV MelanomaWho this might be right forMelanoma Vanderbilt-Ingram Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00001832What this trial is testingLymphocyte Re-infusion During Immune Suppression to Treat Metastatic MelanomaWho this might be right forMelanomaNeoplasm Metastasis National Cancer Institute (NCI) 170
Early research (Phase 1)Ended earlyNCT02110563What this trial is testingPhase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or LymphomaWho this might be right forSolid TumorsMultiple MyelomaNon-Hodgkins Lymphoma+3 more Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 50
Testing effectiveness (Phase 2)Study completedNCT05864144What this trial is testingSNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT00844064What this trial is testingSafety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2Who this might be right forPancreatic NeoplasmsMelanomaColorectal Neoplasms Isarna Therapeutics GmbH 62
Not applicableStudy completedNCT01945762What this trial is testingObservational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid CancerWho this might be right forSymptomatic, Aggressive, Sporadic, Unresectable, LocallyAdvanced/Metastatic Medullary Thyroid Cancer (MTC) Genzyme, a Sanofi Company 31
Testing effectiveness (Phase 2)WithdrawnNCT01689870What this trial is testingStudy of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic MelanomaWho this might be right forMetastatic Melanoma Ludwig Institute for Cancer Research
Testing effectiveness (Phase 2)Looking for participantsNCT03412877What this trial is testingAdministration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic CancerWho this might be right forEndocrine TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more National Cancer Institute (NCI) 285
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237What this trial is testingCabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate CancerWho this might be right forAggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)UnknownNCT04913337What this trial is testingStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forMesotheliomaGlioblastomaRenal Cell Carcinoma+12 more NGM Biopharmaceuticals, Inc 179
Testing effectiveness (Phase 2)Study completedNCT03304639What this trial is testingTesting the Addition of Radiation Therapy to Immunotherapy for Merkel Cell CarcinomaWho this might be right forAdvanced Merkel Cell CarcinomaClinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more National Cancer Institute (NCI) 9
Not applicableUnknownNCT05889481What this trial is testingMorphological, Genetic and Tumour Microenvironment Characterisation in Uveal MelanomaWho this might be right forUveal Melanoma Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Testing effectiveness (Phase 2)Looking for participantsNCT07179783What this trial is testingSacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)Who this might be right forProstate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Castration-ResistantProstate Adenocarcinoma With Neuroendocrine Differentiation Tianjin Medical University Second Hospital 28
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16